Hypothalamic 5-HT functional regulation through 5-HT1A and 5-HT2C receptors during pancreatic regeneration

被引:11
|
作者
Mohanan, VV [1 ]
Khan, R [1 ]
Paulose, CS [1 ]
机构
[1] Cochin Univ Sci & Technol, Dept Biotechnol, Ctr Neurosci, Mol Neurobiol & Cell Biol Unit, Cochin 682022, Kerala, India
关键词
hypothalamus; 5-HT1A receptor; 5-HT2C receptor; pancreas; regeneration;
D O I
10.1016/j.lfs.2005.07.027
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
5-HT receptors are predominantly located in the brain and are involved in pancreatic function and cell proliferation through sympathetic nervous system. The objective of this study was to investigate the role of hypothalamic 5-HT, 5-HT1(A) and 5-HT2(C) receptor binding and gene expression in rat model of pancreatic regeneration using 60% pancreatectomy. The pancreatic regeneration was evaluated by 5-HT content, 5-HT1(A) and 5-HT2(C) receptor gene expression in the hypothalamus of sham operated, 72 h and 7 days pancreatectomised rats. 5-HT content was quantified by HPLC. 5-HT1(A) receptor assay was done by using specific agonist [H-3]8-OH DPAT. 5-HT2(C) receptor assay was done by using specific antagonist [H-3]mesuler-ine. The expression of 5-HT1(A) and 5-HT2(C) receptor gene was analyzed by RT-PCR. 5-HT content was higher in the hypothalamus of 72 h pancreatectomised rats. 5-HT1(A) and 5-HT2(C) receptors were down-regulated in the hypothalamus. RT-PCR analysis revealed decreased 5-HT1(A) and 5-HT2(C) receptor mRNA expression. The 5-HT1(A) and 5-HT2(C) receptors gene expression in the 7 days pancreatectomised rats reversed to near sham level. This study is the first to identify 5-HT1(A) and 5-HT2(C) receptor gene expression in the hypothalamus during pancreatic regeneration in rats. Our results suggest the hypothalamic serotonergic receptor functional regulation during pancreatic regeneration. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:1603 / 1609
页数:7
相关论文
共 50 条
  • [1] 5-HT AGONIST REGULATION OF 5-HT1C RECEPTORS
    SHARMA, A
    FONE, KCF
    BRITISH JOURNAL OF PHARMACOLOGY, 1992, 107 : P7 - P7
  • [2] The 5-HT1A paradox:: Why 5-HT inhibits and 5-HT1A agonists activate pyramidal neurons in prefrontal cortex through 5-HT1A receptors?
    Llado-Pelfort, L.
    Newman-Tancredi, A.
    Perez, F. Artigas
    Pedrosa, P. Celada
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2008, 22 : 112 - 112
  • [3] The serotonin (5-HT)2A and 5-HT2c receptors in nicotine dependence
    Zaniewska, Magdalena
    Filip, Malgorzata
    PHARMACOLOGICAL REPORTS, 2010, 62 : 10 - 10
  • [4] The serotonin (5-HT)2A and 5-HT2C receptors in nicotine dependence
    Magdalena Zaniewska
    Małgorzata Filip
    Pharmacological Reports, 2010, 62 : 10 - 10
  • [5] 5-HT turnover -: the effects of 5-HT1A and 5-HT transporter genotypes
    Armstrong, J.
    Jenkins, T. A.
    Reynolds, G. P.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2008, 22 : 120 - 120
  • [6] 5-HT2A and 5-HT2C receptors and their atypical regulation properties
    Van Oekelen, D
    Luyten, WHML
    Leysen, JE
    LIFE SCIENCES, 2003, 72 (22) : 2429 - 2449
  • [7] Oleamide Analogues as Positive Allosteric Modulators of the Serotonin (5-HT) 5-HT2C and 5-HT2A Receptors
    Chen, Jianping
    Wold, Eric
    Garcia, Erik
    Pazdrak, Konrad
    Wild, Christopher
    Mifflin, Randy
    Chen, Halving
    Anastasio, Noelle
    Cunningham, Kathryn
    Zhou, Jia
    FASEB JOURNAL, 2021, 35
  • [8] Anxiolytic effects of 5-HT1A receptors and anxiogenic effects of 5-HT2C receptors in the amygdala of mice
    Li, Qian
    Luo, Tian
    Jiang, Xue
    Wang, Jing
    NEUROPHARMACOLOGY, 2012, 62 (01) : 474 - 484
  • [9] ARE OTHER 5-HT RECEPTORS BESIDES 5-HT(1A) AND 5-HT(2) INVOLVED IN THE REGULATION OF SLEEP AND WAKEFULNESS
    ADRIEN, J
    JOURNAL OF SLEEP RESEARCH, 1992, 1 (03) : 176 - 177
  • [10] Epigenetic Regulation of Serotonin (5-HT) 5-HT2A:5-HT2C Receptor Balance in Maladaptive Impulsivity
    Anastasio, Noelle C.
    Miller, Aaron L.
    Pyles, Richard B.
    Moeller, F. Gerard
    Ramesh, Divya
    Sowers, Lawrence C.
    Cunningham, Kathryn A.
    NEUROPSYCHOPHARMACOLOGY, 2014, 39 : S330 - S330